Cargando…
Gynecologic malignancy in pregnancy
Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784125/ https://www.ncbi.nlm.nih.gov/pubmed/24328018 http://dx.doi.org/10.5468/ogs.2013.56.5.289 |
_version_ | 1782477520517464064 |
---|---|
author | Ji, Yong Il Kim, Ki Tae |
author_facet | Ji, Yong Il Kim, Ki Tae |
author_sort | Ji, Yong Il |
collection | PubMed |
description | Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic procedures that do not harm the fetus can be used. Laparoscopic surgery or laparotomy may be safely performed. The staging approach and treatment should be standard. Systemic chemotherapy during the first trimester should be delayed if possible. Radiation therapy should preferably start postpartum. Although delivery should be delayed preferably until after 35 weeks of gestation, termination of pregnancy may be considered when immediate treatment is required. Subsequent pregnancies do not increase the risk of malignancy recurrence. |
format | Online Article Text |
id | pubmed-3784125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology |
record_format | MEDLINE/PubMed |
spelling | pubmed-37841252013-12-10 Gynecologic malignancy in pregnancy Ji, Yong Il Kim, Ki Tae Obstet Gynecol Sci Review Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic procedures that do not harm the fetus can be used. Laparoscopic surgery or laparotomy may be safely performed. The staging approach and treatment should be standard. Systemic chemotherapy during the first trimester should be delayed if possible. Radiation therapy should preferably start postpartum. Although delivery should be delayed preferably until after 35 weeks of gestation, termination of pregnancy may be considered when immediate treatment is required. Subsequent pregnancies do not increase the risk of malignancy recurrence. Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology 2013-09 2013-09-14 /pmc/articles/PMC3784125/ /pubmed/24328018 http://dx.doi.org/10.5468/ogs.2013.56.5.289 Text en Copyright © 2013 Korean Society of Obstetrics and Gynecology http://creativecommons.org/licenses/by-nc/3.0/ Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Ji, Yong Il Kim, Ki Tae Gynecologic malignancy in pregnancy |
title | Gynecologic malignancy in pregnancy |
title_full | Gynecologic malignancy in pregnancy |
title_fullStr | Gynecologic malignancy in pregnancy |
title_full_unstemmed | Gynecologic malignancy in pregnancy |
title_short | Gynecologic malignancy in pregnancy |
title_sort | gynecologic malignancy in pregnancy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784125/ https://www.ncbi.nlm.nih.gov/pubmed/24328018 http://dx.doi.org/10.5468/ogs.2013.56.5.289 |
work_keys_str_mv | AT jiyongil gynecologicmalignancyinpregnancy AT kimkitae gynecologicmalignancyinpregnancy |